On july 4, 2016, the suspect medical device list number changed from 02k91-28 to 02k91-23 and from lot number unknown to lot 50384m500.
On july 15, 2016 the suspect medical device lot number was changed from 50384m500 to 50354m500.
This was updated in model/lot#.
On july 28, 2016 the evaluation was completed.
Further investigation of the customer issue included a review of the complaint text, a search for similar complaints, review of instrument logs, a review of labeling and accuracy testing.
Historical performance of the reagent lot was evaluated using world wide data from abbott link.
The patient data was analyzed and compared to an established control limit.
This evaluation indicated that the patient median result for this lot is within the established control limits and no unusual reagent lot performance was identified.
No adverse trend was identified for the customer's issue.
Labeling was reviewed and found to be adequate.
The product was not available for return.
An internal panel was tested with retained kits of the likely cause reagent lot and accuracy testing met all specifications.
Based on all available information and abbott diagnostics' complaint investigation, the assay performed as intended and no product deficiency was identified.
|
The device evaluation was reassessed and concluded that a malfunction occurred, therefore, the device was not performing as intended, however, no systemic issue or product deficiency was identified.
|